Summary: Biotechnology company FitBiomics has launched V•Nella, a product aimed at reducing fatigue and improving endurance by optimizing gut health. V•Nella leverages the properties of Veillonella bacteria, which breaks down lactic acid and converts it into beneficial short-chain fatty acids. The development of V•Nella follows FitBiomics’ first product, Nella, which focuses on improving sleep quality, energy, and digestion. These advancements are based on research from Harvard’s Wyss Institute.
Three Key Takeaways:
- Product Launch: FitBiomics has introduced V•Nella, a product designed to reduce fatigue and enhance endurance through gut health optimization.
- Scientific Basis: V•Nella utilizes Veillonella bacteria to break down lactic acid, converting it into beneficial short-chain fatty acids, following research published in Nature Magazine in 2019.
- Previous Products: FitBiomics’ first product, Nella, aimed at improving sleep, energy, and digestion, highlights the company’s focus on microbiome innovation for consumer health solutions.
Biotechnology company FitBiomics has introduced V•Nella, a new product designed to reduce fatigue and improve endurance by optimizing gut health.
V•Nella is named after the genus Veillonella, the good bacteria that breaks down lactic acid, the chemical produced by the body during exercise when breaking down carbohydrates for energy, and converts it into beneficial short-chain fatty acids.
An eight-week, placebo-controlled study found Veillonella significantly reduced multiple categories of fatigue in a sustained and enduring manner and increased physical activity.
“Fatigue is an epidemic that broadly impacts society,” says Jonathan Scheiman, PhD, co-founder and CEO of FitBiomics, in a release. “Our discovery of Veillonella, first published in Nature Magazine in 2019, represents a new paradigm for optimizing our physiology to fight fatigue. Just five years later, FitBiomics has rapidly translated this academic finding to a real-world, clinically validated product and the applications are far-reaching.”
Performance Test
In a recent performance test, V•Nella has demonstrated the ability to:
- Markedly reduce weekly fatigue;
- Significantly enable extra hours of physical activity; and
- Improve endurance during exercise.
In 2021, FitBiomics introduced its first consumer product under the brand Nella. Developed with the company’s patented next-generation Lactobacillus probiotic strains, Nella is a probiotic designed for improved sleep quality, more energy, and better digestion.
These discoveries are the result of technology developed and spun out of Harvard’s Wyss Institute, studying the microbiome of elite athletes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Photo caption: V•Nella
Photo credit: FitBiomics
Leave a Reply